Rare Disease Therapy Afamelanotide Market to Hit USD 258.01 Million...

added blog News & Media

2026-05-25 11:03:04

Rare Disease Therapy Afamelanotide Market to Hit USD 258.01 Million by 2032 at 9.1% CAGR

According to a new report from Intel Market Research, the global Afamelanotide market was valued at USD 136.27 million in 2024 and is projected to reach USD 258.01 million by 2032, growing at a robust CAGR of 9.1% during the forecast period (2025–2032). This growth is propelled by the increasing global prevalence of rare phototoxic disorders, heightened awareness about orphan diseases,...

1 Comments 0 Shares 658 Views 0 Reviews